Top compounds associated with response to ANKRD63


Feature Type Standardized
Nominal ANOVA
mRNA austocystin d CTRPv2 pan-cancer AAC 0.17 3e-05
mRNA OSI-930 CTRPv2 pan-cancer AAC 0.16 3e-05
mRNA BRD-K01737880 CTRPv2 pan-cancer AAC 0.47 3e-05
mRNA decitabine:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.14 5e-05
mRNA paclitaxel CTRPv2 pan-cancer AAC 0.15 5e-05
mRNA decitabine CTRPv2 pan-cancer AAC 0.12 5e-05
mRNA parbendazole CTRPv2 pan-cancer AAC 0.14 6e-05
mRNA KX2-391 CTRPv2 pan-cancer AAC 0.14 6e-05
mRNA carboplatin:etoposide (40:17 mol/mol) CTRPv2 pan-cancer AAC 0.13 7e-05
mRNA AZD-2281 CTRPv2 pan-cancer AAC 0.15 8e-05
Download CSV